SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-130900
Filing Date
2022-04-29
Accepted
2022-04-29 09:09:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d283715ddefa14a.htm DEFA14A 11095
2 GRAPHIC g283715g43c61.jpg GRAPHIC 211064
3 GRAPHIC g283715g66o91.jpg GRAPHIC 331579
  Complete submission text file 0001193125-22-130900.txt   759982
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 22870703
SIC: 2834 Pharmaceutical Preparations